APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acyclovir

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acyclovir Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchAcyclovir Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acyclovir Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Acyclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acyclovir Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Acyclovir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Acyclovir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acyclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acyclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acyclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acyclovir market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acyclovir market include GSK, TEVA, Mylan, Fresenius Kabi, Zydus Pharmaceuticals, Vectans Pharma (Onxeo), Bausch Health and APOTEX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Acyclovir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acyclovir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acyclovir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acyclovir market size, projected growth trends, production technologies, key applications, and end-use industries.

Acyclovir Segment by Company

GSK

TEVA

Mylan

Fresenius Kabi

Zydus Pharmaceuticals

Vectans Pharma (Onxeo)

Bausch Health

APOTEX

Acyclovir Segment by Type

Oral Product

Injection Product

Acyclovir Segment by Application

Hospitals

Clinics

Others

Acyclovir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Acyclovir status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Acyclovir market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acyclovir significant trends, drivers, influence factors in global and regions.

6. To analyze Acyclovir competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acyclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acyclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acyclovir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Acyclovir market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acyclovir industry.

Chapter 3: Detailed analysis of Acyclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Acyclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Acyclovir in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acyclovir Industry Trends Table 2. Acyclovir Industry Drivers Table 3. Acyclovir Industry Opportunities and Challenges Table 4. Acyclovir Industry Restraints Table 5. Global Acyclovir Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acyclovir Revenue Share by Company (2021-2026) Table 7. Global Acyclovir Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Acyclovir Sales Volume Share by Company (2021-2026) Table 9. Global Acyclovir Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Acyclovir Company Ranking, (2024-2026) & (USD Million) Table 11. Global Acyclovir Key Company Manufacturing Base & Headquarters Table 12. Global Acyclovir Company, Product Type & Application Table 13. Global Acyclovir Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Acyclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Product Table 18. Significant Companies of Injection Product Table 19. Global Acyclovir Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Acyclovir Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Acyclovir Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Acyclovir Sales Volume Share by Type (2021-2026) Table 23. Global Acyclovir Sales Volume Share by Type (2027-2032) Table 24. Global Acyclovir Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Acyclovir Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Acyclovir Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Acyclovir Sales Value Share by Type (2021-2026) Table 28. Global Acyclovir Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Acyclovir Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Acyclovir Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Acyclovir Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Acyclovir Sales Volume Share by Application (2021-2026) Table 36. Global Acyclovir Sales Volume Share by Application (2027-2032) Table 37. Global Acyclovir Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Acyclovir Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Acyclovir Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Acyclovir Sales Value Share by Application (2021-2026) Table 41. Global Acyclovir Sales Value Share by Application (2027-2032) Table 42. Global Acyclovir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Acyclovir Sales by Region (2021-2026) & (K Units) Table 44. Global Acyclovir Sales Market Share by Region (2021-2026) Table 45. Global Acyclovir Sales by Region (2027-2032) & (K Units) Table 46. Global Acyclovir Sales Market Share by Region (2027-2032) Table 47. Global Acyclovir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Acyclovir Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Acyclovir Sales Value Share by Region (2021-2026) Table 50. Global Acyclovir Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Acyclovir Sales Value Share by Region (2027-2032) Table 52. Global Acyclovir Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Acyclovir Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Acyclovir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Acyclovir Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Acyclovir Sales by Country (2021-2026) & (K Units) Table 57. Global Acyclovir Sales Market Share by Country (2021-2026) Table 58. Global Acyclovir Sales by Country (2027-2032) & (K Units) Table 59. Global Acyclovir Sales Market Share by Country (2027-2032) Table 60. Global Acyclovir Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Acyclovir Sales Value Market Share by Country (2021-2026) Table 62. Global Acyclovir Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Acyclovir Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Acyclovir Product Portfolio Table 68. GSK Recent Development Table 69. TEVA Company Information Table 70. TEVA Business Overview Table 71. TEVA Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. TEVA Acyclovir Product Portfolio Table 73. TEVA Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Mylan Acyclovir Product Portfolio Table 78. Mylan Recent Development Table 79. Fresenius Kabi Company Information Table 80. Fresenius Kabi Business Overview Table 81. Fresenius Kabi Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Fresenius Kabi Acyclovir Product Portfolio Table 83. Fresenius Kabi Recent Development Table 84. Zydus Pharmaceuticals Company Information Table 85. Zydus Pharmaceuticals Business Overview Table 86. Zydus Pharmaceuticals Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Zydus Pharmaceuticals Acyclovir Product Portfolio Table 88. Zydus Pharmaceuticals Recent Development Table 89. Vectans Pharma (Onxeo) Company Information Table 90. Vectans Pharma (Onxeo) Business Overview Table 91. Vectans Pharma (Onxeo) Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Vectans Pharma (Onxeo) Acyclovir Product Portfolio Table 93. Vectans Pharma (Onxeo) Recent Development Table 94. Bausch Health Company Information Table 95. Bausch Health Business Overview Table 96. Bausch Health Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Bausch Health Acyclovir Product Portfolio Table 98. Bausch Health Recent Development Table 99. APOTEX Company Information Table 100. APOTEX Business Overview Table 101. APOTEX Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. APOTEX Acyclovir Product Portfolio Table 103. APOTEX Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Acyclovir Distributors List Table 107. Acyclovir Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Acyclovir Product Image Figure 2. Global Acyclovir Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acyclovir Sales Value (2021-2032) & (US$ Million) Figure 4. Global Acyclovir Sales (2021-2032) & (K Units) Figure 5. Global Acyclovir Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Acyclovir Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Product Image Figure 10. Injection Product Image Figure 11. Global Acyclovir Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Acyclovir Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Acyclovir Sales Volume Share by Type (2021-2032) Figure 14. Global Acyclovir Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Acyclovir Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Acyclovir Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Acyclovir Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Acyclovir Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Acyclovir Sales Volume Share by Application (2021-2032) Figure 23. Global Acyclovir Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Acyclovir Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Acyclovir Sales Value Share by Application (2021-2032) Figure 26. Global Acyclovir Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Acyclovir Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Acyclovir Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Acyclovir Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Acyclovir Sales Value (2021-2032) & (US$ Million) Figure 31. North America Acyclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Acyclovir Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Acyclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Acyclovir Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Acyclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Acyclovir Sales Value (2021-2032) & (US$ Million) Figure 37. South America Acyclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Acyclovir Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Acyclovir Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Acyclovir Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Acyclovir Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Acyclovir Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Acyclovir Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Acyclovir Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Product
  • Injection Product
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • GSK
  • TEVA
  • Mylan
  • Fresenius Kabi
  • Zydus Pharmaceuticals
  • Vectans Pharma (Onxeo)
  • Bausch Health
  • APOTEX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acyclovir Sales Value (2021-2032)
  4. 1.2.2 Global Acyclovir Sales Volume (2021-2032)
  5. 1.2.3 Global Acyclovir Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Acyclovir Market Dynamics
  1. 2.1 Acyclovir Industry Trends
  2. 2.2 Acyclovir Industry Drivers
  3. 2.3 Acyclovir Industry Opportunities and Challenges
  4. 2.4 Acyclovir Industry Restraints
3 Acyclovir Market by Company
  1. 3.1 Global Acyclovir Company Revenue Ranking in 2025
  2. 3.2 Global Acyclovir Revenue by Company (2021-2026)
  3. 3.3 Global Acyclovir Sales Volume by Company (2021-2026)
  4. 3.4 Global Acyclovir Average Price by Company (2021-2026)
  5. 3.5 Global Acyclovir Company Ranking (2024-2026)
  6. 3.6 Global Acyclovir Company Manufacturing Base and Headquarters
  7. 3.7 Global Acyclovir Company Product Type and Application
  8. 3.8 Global Acyclovir Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Acyclovir Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Acyclovir Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Acyclovir Market by Type
  1. 4.1 Acyclovir Type Introduction
  2. 4.1.1 Oral Product
  3. 4.1.2 Injection Product
  4. 4.2 Global Acyclovir Sales Volume by Type
  5. 4.2.1 Global Acyclovir Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Acyclovir Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Acyclovir Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Acyclovir Sales Value by Type
  9. 4.3.1 Global Acyclovir Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Acyclovir Sales Value by Type (2021-2032)
  11. 4.3.3 Global Acyclovir Sales Value Share by Type (2021-2032)
5 Acyclovir Market by Application
  1. 5.1 Acyclovir Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Acyclovir Sales Volume by Application
  6. 5.2.1 Global Acyclovir Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acyclovir Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Acyclovir Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Acyclovir Sales Value by Application
  10. 5.3.1 Global Acyclovir Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Acyclovir Sales Value by Application (2021-2032)
  12. 5.3.3 Global Acyclovir Sales Value Share by Application (2021-2032)
6 Acyclovir Regional Sales and Value Analysis
  1. 6.1 Global Acyclovir Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acyclovir Sales by Region (2021-2032)
  3. 6.2.1 Global Acyclovir Sales by Region: 2021-2026
  4. 6.2.2 Global Acyclovir Sales by Region (2027-2032)
  5. 6.3 Global Acyclovir Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Acyclovir Sales Value by Region (2021-2032)
  7. 6.4.1 Global Acyclovir Sales Value by Region: 2021-2026
  8. 6.4.2 Global Acyclovir Sales Value by Region (2027-2032)
  9. 6.5 Global Acyclovir Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Acyclovir Sales Value (2021-2032)
  12. 6.6.2 North America Acyclovir Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Acyclovir Sales Value (2021-2032)
  15. 6.7.2 Europe Acyclovir Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Acyclovir Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Acyclovir Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Acyclovir Sales Value (2021-2032)
  21. 6.9.2 South America Acyclovir Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Acyclovir Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Acyclovir Sales Value Share by Country, 2025 VS 2032
7 Acyclovir Country-level Sales and Value Analysis
  1. 7.1 Global Acyclovir Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acyclovir Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Acyclovir Sales by Country (2021-2032)
  4. 7.3.1 Global Acyclovir Sales by Country (2021-2026)
  5. 7.3.2 Global Acyclovir Sales by Country (2027-2032)
  6. 7.4 Global Acyclovir Sales Value by Country (2021-2032)
  7. 7.4.1 Global Acyclovir Sales Value by Country (2021-2026)
  8. 7.4.2 Global Acyclovir Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Acyclovir Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Acyclovir Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Acyclovir Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Acyclovir Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Acyclovir Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Acyclovir Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Acyclovir Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Acyclovir Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Acyclovir Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Acyclovir Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Acyclovir Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Acyclovir Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Acyclovir Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Acyclovir Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Acyclovir Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Acyclovir Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Acyclovir Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Acyclovir Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Acyclovir Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Acyclovir Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Acyclovir Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Acyclovir Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Acyclovir Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Acyclovir Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Acyclovir Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Acyclovir Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Acyclovir Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Acyclovir Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Acyclovir Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Acyclovir Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Acyclovir Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Acyclovir Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Acyclovir Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Acyclovir Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Acyclovir Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Acyclovir Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Acyclovir Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Acyclovir Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Acyclovir Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Acyclovir Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Acyclovir Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Acyclovir Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Acyclovir Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Acyclovir Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Acyclovir Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Acyclovir Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Acyclovir Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Acyclovir Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Acyclovir Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Acyclovir Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Acyclovir Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Acyclovir Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Acyclovir Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Acyclovir Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Acyclovir Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Acyclovir Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Acyclovir Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Acyclovir Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Acyclovir Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Acyclovir Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Acyclovir Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Acyclovir Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Acyclovir Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Acyclovir Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Acyclovir Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Acyclovir Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Acyclovir Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Acyclovir Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Acyclovir Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Acyclovir Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Acyclovir Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Acyclovir Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Acyclovir Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Acyclovir Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Acyclovir Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Acyclovir Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Acyclovir Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Acyclovir Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Acyclovir Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Acyclovir Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Acyclovir Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Acyclovir Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Acyclovir Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Acyclovir Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Acyclovir Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Acyclovir Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 TEVA
  8. 8.2.1 TEVA Company Information
  9. 8.2.2 TEVA Business Overview
  10. 8.2.3 TEVA Acyclovir Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 TEVA Acyclovir Product Portfolio
  12. 8.2.5 TEVA Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Acyclovir Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Acyclovir Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Acyclovir Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Acyclovir Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Zydus Pharmaceuticals
  26. 8.5.1 Zydus Pharmaceuticals Company Information
  27. 8.5.2 Zydus Pharmaceuticals Business Overview
  28. 8.5.3 Zydus Pharmaceuticals Acyclovir Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Pharmaceuticals Acyclovir Product Portfolio
  30. 8.5.5 Zydus Pharmaceuticals Recent Developments
  31. 8.6 Vectans Pharma (Onxeo)
  32. 8.6.1 Vectans Pharma (Onxeo) Company Information
  33. 8.6.2 Vectans Pharma (Onxeo) Business Overview
  34. 8.6.3 Vectans Pharma (Onxeo) Acyclovir Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vectans Pharma (Onxeo) Acyclovir Product Portfolio
  36. 8.6.5 Vectans Pharma (Onxeo) Recent Developments
  37. 8.7 Bausch Health
  38. 8.7.1 Bausch Health Company Information
  39. 8.7.2 Bausch Health Business Overview
  40. 8.7.3 Bausch Health Acyclovir Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bausch Health Acyclovir Product Portfolio
  42. 8.7.5 Bausch Health Recent Developments
  43. 8.8 APOTEX
  44. 8.8.1 APOTEX Company Information
  45. 8.8.2 APOTEX Business Overview
  46. 8.8.3 APOTEX Acyclovir Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 APOTEX Acyclovir Product Portfolio
  48. 8.8.5 APOTEX Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Acyclovir Value Chain Analysis
  2. 9.1.1 Acyclovir Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Acyclovir Sales Mode & Process
  6. 9.2 Acyclovir Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Acyclovir Distributors
  9. 9.2.3 Acyclovir Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst